Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06160700 · ClinicalTrials.gov registry record
Serial Testing To Assess Cognitive Function In Cancer
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 54
- Enrollment target
NCT06160700: Clinical Trial study, sponsored by Indiana University.
NCT06160700 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06160700 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of immunotherapy on cognitive function of cancer patients and follow them clinically over a period of six months with the Montreal cognitive assessment (MoCA) to assess changes in cognition.
Primary Outcome
The changes in MoCA scores over 6 months in patients from each group will be plotted and summarized with mean change, standard deviation of change, and standard errors of mean change. The standardized response mean (SRM), calculated as the mean change from baseline to 6 months, divided by the standard deviation of change, will be reported as the main effect size for evaluating the magnitude of change in cognitive function.
Interventions
- BEHAVIORAL Montreal Cognitive Assessment (MoCA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-04-20 |
| Est. Completion | 2024-03-12 |
Why NCT06160700 stopped before completion
NCT06160700 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Montreal Cognitive Assessment (MoCA) is the first listed.
NCT06160700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06160700 about?
NCT06160700 is a clinical study titled "Serial Testing To Assess Cognitive Function In Cancer". The purpose of this study is to examine the effects of immunotherapy on cognitive function of cancer patients and follow them clinically over a period of six months with the Montreal cognitive assessment (MoCA) to assess changes in cognition.
What is the current status of trial NCT06160700?
This trial is currently terminated. The enrollment target is 54 participants. The study started on 2022-04-20. Estimated completion is 2024-03-12.
What interventions are being tested in trial NCT06160700?
The interventions under investigation include: Montreal Cognitive Assessment (MoCA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06160700?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI